Actavis Group ("ACT"), the international generic pharmaceuticals
company, announces today that Svafa Gronfeldt, Deputy to the CEO,
will leave the Company in December 2006 to become the Dean of
Reykjavik University. Svafa will continue to work for Actavis on
specific projects in the coming months.
Sigurdur Oli Olafsson, Executive Vice President of the North America
sales division, will now become the Deputy CEO of the Group, as of 1
December 2006, in addition to his current responsibilities. Olafsson,
a Pharmacist from the University of Iceland, joined Actavis in 2003
after working for Pfizer UK from 1998 and then Pfizer in the US from
2001 where he worked in Global Research and Development. Previously
Olafsson served as Marketing Manager for an Actavis subsidiary, later
becoming Drug Development Manager.
Robert Wessman, Chief Executive of Actavis, said:
"Svafa has done a tremendous job during her time at Actavis and on
behalf of the Executive Board, I would like to thank her for her
dedication and contribution."
For further information:
Halldor Kristmannsson
Vice President of Actavis Corporate Communications and IR
Tel: +354 535 2300 / 354 840 3425
hkristmannsson@actavis.com
http://hugin.info/134004/R/1090084/191871.jpg
http://hugin.info/134004/R/1090084/191875.jpg
Copyright © Hugin ASA . All rights reserved.